These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33569062)

  • 1. The Immunobiogram, a Novel
    Portoles JM; Jimenez C; Janeiro D; Lopez-Oliva MO; Ortega-Carrion A; Blanquez D; Arribas L; Gomez C; Diez T; Pascual J; Portero I
    Front Immunol; 2020; 11():618202. PubMed ID: 33569062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IMBG Test for Evaluating the Pharmacodynamic Response to Immunosuppressive Therapy in Kidney Transplant Patients: Current Evidence and Future Applications.
    Pascual J; Crespo M; Portoles J; Jimenez C; Ortega-Carrion A; Diez T; Portero I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients.
    Pascual J; Jiménez C; Krajewska M; Seron D; Kotton CN; Portolés J; Witzke O; Sorensen SS; Andrés A; Crespo M; Paz-Artal E; Díez T; Ortega A; Portero I
    Transpl Immunol; 2022 Dec; 75():101711. PubMed ID: 36096417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine.
    Hirano T
    Int Immunopharmacol; 2007 Jan; 7(1):3-22. PubMed ID: 17161812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.
    Israeli M; Ben-Gal T; Yaari V; Valdman A; Matz I; Medalion B; Battler A; Sredni B; Kristt D; Klein T
    Transplantation; 2010 Apr; 89(8):968-76. PubMed ID: 20075792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Profiling of Kidney Transplant Recipients With Immunosuppressive Treatment Reveals the Dynamic Immune Characteristics.
    Liu Y; Liu X; Zhou S; Xu R; Hu J; Liao G; Liao J; Guo Z; Li Y; Yang S; Li S; Chen H; Guo Y; Li M; Fan L; Li L; Zhao M; Liu D
    Front Immunol; 2021; 12():639942. PubMed ID: 33959124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-regulatory cells in chronic rejection versus stable grafts.
    Al-Wedaie F; Farid E; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():170-6. PubMed ID: 25894149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.
    Millán O; Urtasun N; Brunet M
    Transplant Rev (Orlando); 2009 Apr; 23(2):120-8. PubMed ID: 19298943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivities of peripheral blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation.
    Mijiti A; Matsuno N; Iwahori T; Takeuchi H; Nagao T; Oka K; Hirano T
    Cell Transplant; 2006; 15(10):885-91. PubMed ID: 17299993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
    Barraclough KA; Staatz CE; Isbel NM; McTaggart SJ
    Nephrology (Carlton); 2010 Aug; 15(5):522-32. PubMed ID: 20649871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.
    Zucker C; Zucker K; Asthana D; Carreno M; Viciana AL; Ruiz P; Esquenazi V; Nery J; Burke G; Miller J
    Hum Immunol; 1996 Jan; 45(1):1-12. PubMed ID: 8655354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts and perspectives of immunosuppression in organ transplantation.
    Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
    Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.
    Riglet F; Bertrand J; Barrail-Tran A; Verstuyft C; Michelon H; Benech H; Durrbach A; Furlan V; Barau C
    Drugs R D; 2020 Dec; 20(4):331-342. PubMed ID: 33025511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pharmacodynamic biomarkers and clinical events in the early phase after kidney transplantation: a single-center pilot study.
    Wieland E; Shipkova M; Martius Y; Hasche G; Klett C; Bolley R; Olbricht CJ
    Ther Drug Monit; 2011 Jun; 33(3):341-9. PubMed ID: 21516058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Acute Cellular Rejection With Detrimental Outcome Occurring Under Belatacept-Based Immunosuppressive Therapy: An Immunological Analysis.
    de Graav GN; Hesselink DA; Dieterich M; Kraaijeveld R; Douben H; de Klein A; Roelen DL; Weimar W; Roodnat JI; Clahsen-van Groningen MC; Baan CC
    Transplantation; 2016 May; 100(5):1111-9. PubMed ID: 26599491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro.
    Xu J; Lucas R; Schuchmann M; Kühnle S; Meergans T; Barreiros AP; Lohse AW; Otto G; Wendel A
    J Immunol; 2003 Jul; 171(2):938-47. PubMed ID: 12847265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.